CBIO

Crescent Biopharma

77 hedge funds and large institutions have $567M invested in Crescent Biopharma in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less funds holding

Funds holding: 8177 (-4)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

Holders
77
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$826K
Puts
$660K
Net Calls
Net Calls Change

Top Sellers

1 -$4.42M
2 -$2.58M
3 -$1.89M
4
Marshall Wace
Marshall Wace
United Kingdom
-$1.5M
5
Citigroup
Citigroup
New York
-$1.29M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.3M
27
$980K
28
$946K
29
$926K
30
$922K
31
$915K
32
$892K
33
$784K
34
$743K
35
$681K
36
$655K
37
$623K
38
$567K
39
$567K
40
$540K
41
$465K
42
$437K
43
$402K
44
$352K
45
$331K
46
$306K
47
$293K
48
$280K
49
$271K
50
$265K